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ABSTRACT 
A recent study using human fecal samples in conjunction with a culture-independent 
approach revealed immense diversity of antibiotic resistance (AR) genes in the human gut 
microflora. We hypothesize that food animal gut microflora also contain diverse and novel AR 
genes which could contribute to the emergence and transmission of AR in pathogens important 
in animal and human health. To test this, we examined AR reservoir in chicken gut microflora 
using a metagenomic, functional cloning method. Total genomic DNA was extracted from 
individual cecal contents of two free range chickens and two conventionally raised chickens. 
The DNAs were physically sheered into 1 to 3 kb fragments, cloned into expression vector 
pZE21-MCS, and transformed into E. coli TOP10 host strain, resulting in four metagenomic 
libraries of a total size of 10
8
 base pairs per library. The AR transformants from the libraries 
were selected on plates containing the specific antibiotic of interest; six antibiotics including 
ampicillin, tetracycline, chloramphenicol, spectinomycin, ciprofloxacin and norfloxacin were 
used for screening. Plasmids from selected transformants were extracted and subjected to 
sequence analysis of inserted fragments. Identified AR genes were annotated and aligned with 
homologs that have been deposited in GenBank. A total of 12 AR genes and 3 AR genes were 
identified from the microbiome in conventionally raised chickens and free-range chickens, 
respectively. Of the identified 15 AR genes, 8 genes that confer resistance to ampicillin, 
spectinomycin or chloramphenicol shared low sequence similarity (58% - 76% at amino acid 
level) with the corresponding AR genes previously identified using culture-dependent 
approaches. Notably, among the 8 novel AR genes identified in this study, 4 genes also shared 
low sequence similarities (59%-76% at amino acid level) with recently identified AR genes in 
iv 
human gut.  An E. coli-Campylobacter shuttle vector bearing the flaA sigma 28 promoter was 
constructed. Two novel genes conferring resistance to ampicillin (FRAmp1.1) and 
spectinomycin (FRSpe1.1) were cloned into this new expression vector, respectively. The 
derived vectors have conferred increased AR in C. jejuni, a leading zoonotic bacterial pathogen 
causing human gastroenteritidis in many industrialized countries. Together, findings from this 
study showed the effectiveness of the metagenomic approach for examination of AR reservoir 
in food animals, revealed novel AR resistance genes in chicken gut microflora, and 
demonstrated the functionality of such AR genes in foodborne human pathogens. 
 
Key words: gut microflora, antibiotic resistance, metagenomics, functional cloning 
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REVIEW OF LITERATURE 
Zoonotic pathogens and infectious diseases in food animals 
Zoonotic pathogens, including viruses, bacteria, and parasites, are a major cause of 
animal infectious diseases. For domesticated animals, the consequences of infectious disease 
include the loss in productivity, loss of incomes from activities using animal resources, cost of 
disease control as well as impacts on food safety and quality. Viral infections are responsible 
for some highly contagious animal diseases. For instance, avian infectious bronchitis virus 
causes avian infectious bronchitis (Kahn 2006), a highly contagious respiratory disease in 
poultry, seriously affecting growth and performance of broilers as well as egg production and 
quality in layers and breeders. Aphthovirus, a severe plague for animal farming, is highly 
contagious and can be spread through contact with various sources of contamination and even 
aerosols. This virus causes Foot-and-Mouth disease in cloven-hoofed animals (Martinez-Salas 
2008), named after its typical symptom of oral and feet blisters. A serious outbreak of 
foot-and-mouth disease in the United Kingdom in 2001 caused an economic loss of $16 billion.  
Bacterial pathogens also cause many infectious diseases in food animals. For instance, 
Clostridium perfringens causes necrotic enteritis in poultry, which is one of the most common 
and financially devastating diseases in broiler flocks (Van Immerseel, De Buck et al. 2004). C. 
perfringens causes growth depression, and in acute forms, even death without clinical signs in 
birds. The average cost for this disease can be as high as 5 US cents per bird (Anonymous 
2000). Salmonella species can induce enteric lesions in chickens (Porter 1998). Salmonella 
pullorum causes life-long infections and induces pullorum disease that is most lethal in young 
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birds and can be transmitted through various mechanisms. Salmonella gallinarum causes fowl 
typhoid that has similar clinical signs with pullorum disease. Paratyphoid group of Salmonella 
can also cause systematic infection in young chickens with high mortality (Porter 1998).  
 
Zoonotic pathogens, food safety and public health 
Besides the infection of animals, zoonotic pathogens also have the potential to infect 
humans, thus resulting in public health problems. Throughout human history, zoonotic 
pathogens have played vital roles in large infectious events. For example, Black death is 
believed to be caused by Yersinia pestis carried by rodent. The 1918 flu pandemic is thought to 
be caused by an Encephalitis virus carried by various animal vectors. The HIV virus is 
hypothesized to evolve from closely related Simian immunodeficiency virus carried by 
non-human primates (Lederberg 1997). More than half of the recognized human pathogens are 
zoonotic, and almost all of the most important human pathogens have animal origins (Taylor, 
Latham et al. 2001; Woolhouse and Gowtage-Sequeria 2005; Wolfe, Dunavan et al. 2007). 
Transmission of zoonotic pathogens to humans is facilitated by the close interaction between 
human and animals, especially after a large set of animals became domesticated. Besides 
physical, airborne and fecal-oral contacts, which are mainly involved in disease transmission in 
food production, food contamination becomes a major route of transmission of zoonotic 
pathogens to humans. More than 250 different foodborne diseases have been described, most 
of which are infections caused by a variety of bacteria, viruses and parasites (CDC 2010). CDC 
estimates that 76 million Americans get sick, more than 300,000 are hospitalized, and 5,000 
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people die from foodborne illnesses each year (CDC 2010). Campylobacter infection is the 
most commonly reported bacterial cause of human enteritidis in the United States. Chickens 
and turkeys are major reservoirs of Campylobacter and therefore the major source for human 
campylobacteriosis (Nachamkin 2008). There are 2.1- 2.4 million estimated cases of 
campylobacteriosis in the United States each year, and the annual medical and productivity 
costs resulting from Campylobacter infection are estimated at 1.5- 8.0 billion dollars 
(Altekruse, Stern et al. 1999; Mead, Slutsker et al. 1999). Salmonella infection, the second 
most common cause of foodborne enteric infections, is caused mainly by the paratyphoid 
group of Salmonella including Salmonella enteritidis, which are found generally in chicken 
carcasses, eggs, and egg products. In August 2010, 380 million eggs coming from Wright 
County Egg of Galt, Iowa were recalled in several states because of suspected Salmonella 
contamination. Salmonella infections in humans account for 1.4 million salmonellosis, 415 
deaths, and $2.65 billion cost each year (Mead, Slutsker et al. 1999) in the United States. E.coli 
O157:H7, commonly found in intestines of healthy goats and cattle, can be spread through 
fecal-oral routes. E. coli O157:H7 causes no disease in cattle and has been found in all age 
groups (USDA 1997). Contaminated beef, water and vegetables are major sources of human 
E.coli O157:H7 infections. E.coli O157:H7 causes 73,000 cases, 61 deaths, and a $478.4 
million cost annually in the United States (Mead, Slutsker et al. 1999). 
 
Antibiotic usage and development of antibiotic resistance 
Originally produced by or derived from fungi, bacteria or other microorganisms, 
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antibiotics have been successfully used for treatment of bacterial infections in human and 
animals. Through therapeutic application of antibiotics, mortality rates associated with 
bacterial infections decreased significantly, compared with before the 1930s when antibiotics 
had not been introduced (Overbye and Barrett 2005). In food animals, antibiotics are more 
widely used comparing with the therapeutic use in humans (van den Bogaard and Stobberingh 
1999). Application of antibiotics in domestic animals includes both therapeutic and 
non-therapeutic uses. The therapeutic uses of antibiotics in domestic animals are under strict 
regulations. These antibiotics include amoxicillin, sulfonamides, tylosin, fluoroquinolones, 
lincosamides, aminoglycosides, tetracyclines, colistin and pleuromutilins (Gyles 2008). In most 
western countries, these antimicrobials can only be applied to a particular group of animals, for 
a defined period of time, and only upon prescription from a veterinarian to cure or prevent 
some specific bacterial infections (van den Bogaard and Stobberingh 1999). However, usage of 
antibiotics as non-therapeutic antimicrobial growth promoters (AGP) is much less restricted. 
These antibiotics include zinc bacitracin, procaine penicillin, tetracyclines, tylosin, 
virginamycin and monensin (Gyles 2008). According to the European Federation of Animal 
Health Industries, of the World Animal Health Product Market 44% were therapeutic 
pharmaceutical products and 41% AGP feed additives (Miller 1993). According to an estimate 
by Levy (1998), more than 80% of all tetracycline and benzylpenicillin were used as AGP in 
the US. Given that epidemiological studies have linked AGP application to the emergence of 
antibiotic resistant bacteria (Wegener 2003), Denmark banned all AGPs in 1998 and European 
Union member nations banned all AGPs in 2006 (Wegener 2003; Dibner and Richards 2005). 
Although there has been little regulatory activity regarding AGP use in the United States, 
consumer pressure, market limitations, and export restrictions are causing commerce to 
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withdraw AGPs from market (Dibner and Richards 2005) 
Antibiotic resistance (AR) is a phenomenon where microorganisms become 
insensitive to exposure to antibiotics. It is initially developed in antibiotic producing organisms 
in order to help them to resist the antimicrobial effect of their own products. For instance, 
Streptomycetes produce beta-lactamases to resist beta-lactam produced by themselves 
(Forsman, Haggstrom et al. 1990). It has been estimated that there exist over 20,000 potential 
AR genes in bacteria with 400 different classes (Liu and Pop 2009).  
AR is an especially serious issue in pathogenic bacteria. When pathogens develop AR, 
the infections are harder to cure, and alternative and effective drugs are often not readily 
available. Nowadays, development of AR is accelerating (Alene and Bennett 1996), 
nonetheless the speed of the discovery and introduction of new antimicrobial drugs are slowing 
down (Lapara 2006). An estimated 38 deaths happen per day caused by hospital acquired 
antibiotic resistant pathogens alone among Americans (WHO 2000). The economic impact is 
also severe, for instance, the costs to bring a new drug onto the market are estimated at a 
minimum of $ 1.3-1.7 billion (Collier 2009), while the overall annual cost considering issues 
like therapeutic treatment, development of new drugs, maintenance of the life of old drugs and 
reduction of forces leading to resistance was estimated to be at least $ 4 to 5 billion (McGowan 
2001).  
It is believed that antibiotic usage in both human and animals may select for AR 
bacteria, either in commensal or pathogenic bacteria. For human, imprudent use of 
antimicrobial drugs is deemed as a cause for the rapid development of drug resistant pathogens. 
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Community usage of antibiotics is expanding AR gene reservoirs (van den Bogaard and 
Stobberingh 1999). Intensive care units (ICUs) are still considered to be the major breeding 
grounds of resistant pathogens because of the effect of surgery, manipulation as well as 
prolonged hospital stay on the host, and most importantly the patients' exposure to multiple 
antimicrobial drugs which selects for AR pathogens. Nosocomial infections caused by AR 
micro-organisms can date back to the discovery of penicillin resistant Staphylococcus aureus 
in the 1950s (Wilson and Cockcroft 1952). In the 1960s, multidrug resistant Gram-negative 
bacilli became responsible for many nosocomial infections (Swartz 1994; Itokazu, Quinn et al. 
1996). The extensive usage of methicillin brought about the methicillin resistant 
Coagulase-negative staphylococci S. aureus, as important nosocomial pathogens in the 1980s 
(Wilkinson, Maxwell et al. 1980). Use of vancomycin as a cure for these infections then 
aroused vancomycin resistant enterococci (Dixson, Brumfitt et al. 1985). Antibiotic usage in 
animals has significant influences on selection of AR bacterial pathogens. For example, use of 
enrofloxacin rapidly selected high-level fluoroquinolone resistant Campylobacter in poultry 
(Luo, Sahin et al. 2003). In animals, antibiotics used as AGPs lead to a long-term selective 
pressure at sub-inhibitory concentrations. There are several examples of the direct impact of 
AGP usage in antimicrobial resistance development. For example, poultry and pigs fed tylosin 
and bacitracin shed enterococci that were resistant to the antibiotics (Rosen 1995). An increase 
in resistance against quinupristin dalfopristin in fecal E. faecium was observed in turkeys given 
virginiamycin as AGP. Fecal E.coli tends to display enhanced resistance against olaquindox 
when fed to pigs (Rosen 1995). Feeding chicken with tylosin at a growth promoting dose 
resulted in the emergence of erythomycin resistant Campylobacter (Lin, Yan et al. 2007). 
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Mechanism of AR in bacteria. 
Although the exact AR mechanisms and genes underlying mechanisms are widely 
diversified, there are three general mechanisms of AR resistance in bacteria. First, mutations 
on the drug target may decrease binding affinity of drugs to the target, hindering the proper 
function of the drug. Similarly, protection proteins may be produced to cover the drug target 
from being bound by drugs. Second, bacteria may destroy the correct structure of drug 
molecules by synthesizing enzymes that catalyzes the covalent modification or degradation of 
drug molecules. Third, bacteria may decrease drug uptake by altering membrane permeability, 
or increase active efflux of the drug through the function of drug efflux pumps. Although some 
of the drug efflux systems are substrate-specific, several else can confer multi-drug resistance, 
and even resistance against natural molecules other than antibiotics (Piddock 2006). The 
following are mechanisms of bacterial resistance to specific group of antibiotics. 
Beta-lactam resistance  
Beta-lactam is one of the most prevalent groups of antibiotics. It is a general term 
regarding all antibiotic agents which have a lactam with a heteroatomic ring structure 
(beta-lactam ring). The general mode of action of beta-lactams is inhibition of peptidoglycan 
synthesis of bacterial cell wall by binding to and blocking transpeptidase in the periplasm. 
Three general mechanisms may result in beta-lactam resistance in bacteria: enzyme 
degradation of the compound, mutations in the transpeptidase, and drug efflux as well as 
changes in membrane permeability. Except for the alternations of membrane permeability that 
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is mainly observed only in Gram-negative bacteria, other mechanisms are adopted by both 
Gram-positive and Gram-negative bacteria.  
Among the three mechanisms, enzyme degradation is the most commonly observed 
mechanism. Generally, inactivation of beta-lactams is accomplished through hydrolyzing the 
beta-lactam rings in the compounds by beta-lactamases. The beta-lactamase is a large group of 
hydrolase. According to different criteria, it can be classified into four functional groups 
(functional group 1-4) or four molecular classes (classes A-D) (Bush, Jacoby et al. 1995). The 
evolution of beta-lactamases expands their resistance spectrum. Penicillinases are the earliest 
to be identified; they confer resistance to penicillins, but often sensitive to other beta-lactams 
like methicillin. Plasmid encoded penicillinases like TEM-1, TEM-2 and SHV-1 are initially 
responsible for resistance only to penicillins. Therefore, new generation beta-lactam called 
„cephems' are often used as an alternative treatment (Sougakoff 1988). However, point 
mutations in these enzymes soon extended their resistance spectrum. Arising then are the 
Extended Spectrum Beta-Lactamases (ESBLs) that hydrolyzes not only penicillins but also 
extended spectrum cephems (mainly 3rd and 4th generation cephalosporins). For instance, 
TEM-3 beta-lactamase, which is derived from TEM-2 with only two amino acid substitution in 
the active site, can confer resistance to the cephems (Sougakoff 1988; Bradford 2001). Other 
types of ESBLs include CTM-X beta-lactamases which show higher activity against 
cefotaxime compared with other cephems (Seputiene, Linkevicius et al. 2010) and beginning 
to dominate the ESBLs (Seputiene, Linkevicius et al. 2010), and OXA beta-lactamases which 
show high activity against oxacillin and cloxacillin (Paterson and Bonomo 2005).  
In an attempt to enhance antimicrobial effectiveness of beta-lactam antibiotics to 
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bacteria producing beta-lactamases, beta-lactamase inhibitors are combined with beta-lactam to 
overcome resistance. Beta-lactamase inhibitors are typically identical to beta-lactams in 
chemical structure. These inhibitors like clavulanic acid and sulbactams can bind irreversibly 
to beta-lactamases as suicide inhibitors (Bush 1988; Totir, Helfand et al. 2007). However, the 
beta-lactamases that were not susceptible to inhibitors were detected in clinical isolates of 
various bacteria in Europe (Bradford 2001). In addition, AmpC beta-lactamases, another 
distinctive family of beta-lactamse, can hydrolyze third-generation cephems (Sanders 1996) 
and are also resistant to inhibitors (Bradford 2001). Peptide-based inhibitors are being 
developed to overcome these resistance (Huang, Beharry et al. 2003). Still, commonly 
encountered beta-lactamases are hardly capable of hydrolyzing Carbapenems. Nonetheless, 
carbapenemases, a diverse group of beta-lactamases, have been discovered and found to be 
plasmid-mediated (Bradford 2001). Carbapenemases are found in Klebsiella pneumoniae from 
different geographical regions (Koh, Sng et al. 2001; Wong-Beringer 2001; Giakkoupi, 
Xanthaki et al. 2003; Bradford, Bratu et al. 2004; Woodford, Tierno et al. 2004). 
Mutations in transpeptidase, alteration of membrane permeability and possession of 
drug efflux systems contribute more to intrinsic resistance and tend to be comparatively 
moderate in resistance level. They often coordinate with other mechanisms to confer resist the 
inhibiton by beta-lactams. For instance, membrane barrier often works synergistically with 
inducible beta-lactamases to enhance resistance in Pseudomonas aeruginosa (Li, Ma et al. 
1994). Also, active drug-efflux by itself does not confer a high level of resistance to 
beta-lactamases, and is often coupled with the production of beta-lactamases (Li, Ma et al. 
1994; Cavallo, Plesiat et al. 2002).  
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Chloramphenicol resistance 
Chloramphenicol exerts its bacteriostatic effect through binding to the 50S ribosomal 
subunit and inhibiting protein synthesis. Chloramphenicol has a wide antibacterial spectrum 
against a number of Gram-positive and Gram-negative bacteria.  
Resistance to chloramphenicol comes in mainly four forms: mutation of 
the chloramphenicol binding site on the ribosome, reduced membrane permeability, enzymatic 
drug modification that confers high level of resistance, and expression of drug efflux pumps 
(Vecchione, Alexander et al. 2009). Chloramphenicol modification is mainly achieved by 
acetyl-CoA based acetylation on the compound's hydroxyl group catalyzed by chloramphenicol 
acetyltransferase (CAT) (Shaw, Packman et al. 1979; Engel and Prockop 1991). CAT 
holoenzyme is a trimer of subunits at 25kDa. Three chloramphenicol molecules are bound to 
one holoenzyme, with each of the molecule located in a binding pocket at the interface of two 
subunit. The histidine residue (His 195) located in the subunit's C-terminal is vital for 
the catalysis (Leslie 1990). 
Tetracycline resistance 
Tetracycline group of antibiotics, including oxytetracycline, doxycycline, 
methacycline, etc., are polyketide antibiotics that inhibit protein synthesis. Tetracyclines can 
bind to the 30S ribosomal subunit thus blocking the localization of aminoacyl-tRNA to the A 
site of the ribosome.  
The usefulness of tetracycline is compromised greatly by the revealing of tetracycline 
resistance in both Gram-negative and Gram-positive bacteria. Tetracycline resistance comes in 
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three general modes of action: drug efflux, ribosomal protection, and drug modification. 
Drug-efflux genes constitute the largest proportion of tetracycline resistance genes in both 
Gram-negative and Gram-positive bacteria, and more than 25 genes have been discovered 
already (http://faculty.washington.edu/marilynr/tetweb4.pdf). Activities of the tetracycline 
efflux pumps are inducible by presence of tetracycline. In Gram-positive bacteria, the 
induction is achieved by the release of the repressor protein (due to the binding to tetracycline) 
from the operator region of efflux genes(Paulsen, Brown et al. 1996). In Gram-negative 
bacteria, the induction is achieved through the regulation of mRNA structure changes by the 
presence of tetracycline molecule (Paulsen, Brown et al. 1996).  
Ribosome protection is also widely adopted. More than 10 ribosome protection 
proteins have been found (Brown, Mitchell et al. 2008). Ribosome binding proteins show 
considerable sequence identity to bacterial elongation factor G especially at the GTP binding 
site (Sanchez-Pescador, Brown et al. 1988; Burdett 1991). TetM has been determined to have 
ribosome-dependent GTPase activity, which suggests an evolutionary relationship between the 
ribosome protection protein and the elongation factor G (Burdett 1991). 
TetX exemplifies a tetracycline modification enzyme, putatively an oxidoreductase 
(Speer, Bedzyk et al. 1991; Speer, Shoemaker et al. 1992). Its activity requires oxygen and 
NADPH, and functions in E. coli but not in its natural host bacteroides. The clinical 
significance of tetracycline modification is not as high as the other two mechanisms (Speer, 
Bedzyk et al. 1991; Speer, Shoemaker et al. 1992). 
 
Aminoglycoside resistance 
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Aminoglycosides are antibiotics with amino-modified sugar structure. This 
group includes kanamycin, spectinomycin, neomycin, streptomycin, gentamycin, etc. The 
antimicrobial activity of aminoglycosides has several potential mechanisms including 
increasing the  rate of nonsense suppression in genes by interfering with the DNA 
proofreading  process, inhibiting protein synthesis by binding to the 30s, or sometimes 
50s ribosome(Lorian 1996; Champney 2001), and interfering with the integrity of bacterial cell 
membrane (Shakil, Khan et al. 2008). 
Aminoglycoside resistance has four major mechanisms: alternation in membrane 
permeability, efflux of drugs, mutations in ribosome binding site, and enzyme-based 
modification of the drugs. Reduced drug uptake (eg. transport defect), alternation in membrane 
permeability and drug efflux mechanisms all contribute to intrinsic resistance 
(Mingeot-Leclercq, Glupczynski et al. 1999). The resistance level is moderate, but 
the spectrum of resistance is wide, and these mechanisms usually need to couple with a 
secondary mechanism to function effectively (Nikaido 1996; Mingeot-Leclercq, Glupczynski 
et al. 1999). For instance, membrane impermeability of P. aeruginosa was proposed to be 
responsible for aminoglycoside resistance, but later it was elucidated that it needs to 
work together with the MexX-MexY-OpmG efflux pump to function (Nikaido 1996; Jo, 
Brinkman et al. 2003).  
Enzymatic modification is the most common resistance mechanism for 
aminoglycoside resistance. More than 50 enzymes have been discovered to introduce 
covalent modifications on the amino (N-modification) or hydroxyl (O-modification) groups 
of aminoglycosides. The N-modifications are catalyzed by acetyltransferases, which introduces 
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CoA-dependent acetylation at site 3, 2' or 6'. O-modifications are  catalyzed by 
adenyltransferase or phosphotransferase, which introduces ATP- dependent adenylation or 
phosphorylation at site 6, 4', 2'' or 3'' for adenylation and 6, 3', 2'' or 3'' for phosphorylation. 
Modifications introduced by different enzymes at different sites will result in distinctive 
resistance phenotypes regarding the spectrum of aminoglycoside resistance. Certain genes have 
different transferases fused together to achieve bifunctional modifications. For 
instance, N6'-acetyl-O2''- phosphotransferase has been discovered and shown to confer 
resistance to all of the aminoglycosides with the exception of streptomycin (Chow 2000).  
Quinolone resistance 
Quinolones are a group of synthetic antibiotics that inhibit the unwinding and 
duplicating of DNAs through binding to the gyrase in Gram-negative bacteria, typeII 
topoisomerases and topoisomerase IV in Gram-positive bacteria (Gellert, Mizuuchi et al. 
1977).  
Mechanisms of quinolone resistance were once deemed to be mainly mutations in 
gyrase and topoisomerase (target alternations), gyrase protection, and permeability barrier in 
the cell membrane (Ruiz 2003). For instance, plasmid-mediated Qnr proteins can bind to and 
protect gyrase from being targeted by quinolones (Nordmann and Poirel 2005). Later, 
drug-efflux mechanisms arouse attention. For example, the norA gene in Staphylococcus 
aureus encodes a multidrug efflux pump that excludes quinolone from the cell. Inhibitors of 
the NorA pump can improve the activity of quinolone drugs like norfloxacin and ciprofloxacin 
(Ng, Trucksis et al. 1994).  
The synthetic nature of quinolones made it believed that enzymatic modification of 
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the compound is not likely to be developed. However, quinolone acetylation mechanism was 
reported to be responsible for enhanced resistance against ciprofloxacin. Resistance was 
conferred by the product of gene aac(6‟)-Ib, which was adapted from aminoglycoside 
acetyltransferases (Robicsek, Strahilevitz et al. 2006). This acetyltransferase characterizes an 
enzyme that, by introducing modifications onto the drugs, confers resistance to two distinctive 
classes of antibiotics. The report of the enzyme also refreshes the understanding of the speed of 
the development of antibiotic resistance in bacteria, even against a synthetic one.  
 
Role of horizontal gene transfer in AR development and transmission  
Horizontal gene transfer (HGT) (Davies 1994) appears a highly efficient mechanism 
in development and transmission of AR in bacteria. HGT is a process in which an organism 
incorporates genetic material from another non-parental organism. HGT can be facilitated by a 
number of mechanisms, including transformation (direct uptake and expression of foreign 
genetic material), transduction (phage facilitated transfer), and conjugation (transfer through 
cell-cell physical contact). Interestingly, the first report of HGT is an observation of the 
transfer of AR genes between different bacterial strains and species (Ochiai 1959). In 
HGT-based development of AR, donors of AR genes are readily available all around. For 
instance, microorganisms in the environment, like soil or water, constitute an environmental 
antibiotic resistome (Baysarowich, Koteva et al. 2008). These enormous resistomes are 
potentially accessible to pathogens, as it has already been determined that many resistance 
mechanisms in pathogens can also be found in the resistome (Wright 2007; Baysarowich, 
Koteva et al. 2008). Another group of important donors for AR genes are animal commensals. 
Regarding efficiency of HGT, a major advantage of commensal bacteria over environmental 
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bacteria is that transformation and conjugation appear to occur more frequently in densely 
packed cells with physical association, which are typified by commensal bacterial communities 
like on the tooth surface and intestinal tracts (Marshall 2009). 
 
Diversity of gut microflora 
Because of its large surface area and nutrient-rich nature, the mammalian 
gastrointestinal tract (GI tract) turns to be a favorable habitat for microorganisms. The animal 
GI tract is most condensely colonized by microorganisms comparing with any other parts of 
the body surface. The gut microflora participates in different physiological functions including 
metabolic activities, trophic effects on intestinal epithelia and immune system, and barricading 
the invasion of alien microbes including pathogens (Guarner and Malagelada 2003). 
The gut microflora contains an enormous quantity of microorganisms. In humans, the 
gut microflora is estimated to contain about 10
14
 cells, which is 10 times the number of cells 
consisting the human body (Bjorksten, Sepp et al. 2001; Guarner and Malagelada 2003), and 
100 times as many genes as there are in the human genome (Qin, Li et al. 2010). Even 
compared with the microbiota on other parts of the mammalian body, the gut microflora is still 
dominant in quantity. It has been estimated that the colon alone holds 70% of all microbes 
carried by an individual (Whitman, Coleman et al. 1998; Ley, Peterson et al. 2006).   
Microorganisms in the gut microflora are composed of bacteria, archaea, viruses and 
unicellular eukaryotes. Dominated by bacteria, the gut microflora contains more than 50 
bacteria phyla, and more than 500 bacterial species (Xu and Gordon 2003). The vast majority 
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are strict anaerobes, followed by facultative anaerobes and aerobes. In humans, most of the 
organisms from the gut microflora are members of the Firmicutes and Bacteroidetes phyla 
(Hayashi, Sakamoto et al. 2002; Eckburg, Bik et al. 2005). Most Firmicutes falls in the 
Clostridia class (Eckburg, Bik et al. 2005). Substantial proportions of Firmicutes are 
butyrate-producting bacteria and involved in maintenance of normal colonic epithelium (Pryde, 
Duncan et al. 2002; Eckburg, Bik et al. 2005). The Bacteroidetes are the second largest 
population (Eckburg, Bik et al. 2005), and are involved actively in functions like nutrient 
absorption and epithelial cell maintenance (Hooper, Wong et al. 2001; Eckburg, Bik et al. 
2005). Other phyla like Proteobacteria, Verrucomicrobia, Actinobacteria, Fusobacteria, and 
Cyanobacteria constitute a comparatively smaller proportion of the microflora (Eckburg, Bik et 
al. 2005).  
The composition of microorganisms in the gut is not stable over time and not 
homogeneous among species, individuals, and different parts of the intestine. Development of 
the gut microflora is dynamic, and is influenced by parents, environment and age. In poultry, 
Torok et al (2007) showed that the gut microbial community composition changes greatly 
within the first 2-3 weeks of age before stabilizing until 5-6 weeks of age, when a final change 
in community composition was observed. The gut microflora composition also show 
significant differences between chickens raised under conventional poultry conditions and low 
pathogen load isolator, suggesting the effect of environment on the microflora difference 
(Torok 2007). In mammals, parental inoculation plays an important role in the development of 
the gut microflora, thus posing differences between individuals with different parents (Mandar 
and Mikelsaar 1996). The intestine shows longitudinal and latitudinal heterogeneity. 
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Firmicutes and Actinobacteria are more prevalent in the small intestine, while Bacteriodetes 
and Lachnospiraceae are more prevalent in the colon (Frank, St Amand et al. 2007). In 
humans, bacterial species in the intestinal lumen differ from those on the mucus layer; 
Clostridium, Lactobacillus and Enterococcus were found at both sites while Enterobacteriacea 
and Ruminococcus are only present in the lumen (Swidsinski, Loening-Baucke et al. 2005). 
Our understanding of the gut microflora is largely incomplete. One of the most 
important reasons is that in the gut microflora, a large proportion of the bacterial species are 
unculturable in the laboratory. This theory was first proposed by Langendijk, who found that 
only 15% DAPI (4'-6-diamidino-2-phenylindole) counts belonged to culturable bacteria by 
fluorescence in situ hybridization (FISH) with bifidobacterium probes (Langendijk, Schut et al. 
1995). This suggests that the proportion of unculturable bacteria in the gut is substantial, and 
very likely constitutes the majority of the microflora. Thus, conventional culture-dependent 
methodologies inevitably introduce bias against unculturable bacteria when used to study gut 
microflora. In the past decade, culture-independent molecular techniques, particularly 16S 
ribosomal RNA gene (rDNA)-based approaches for prokaryotes have been increasingly used to 
examine diversity of gut microbota and significant progress has been made to understand the 
structure and diversity of microbial communities in the gut (Eckburg, Bik et al. 2005). Several 
16S rDNA-based molecular approaches have been used widely to study intestinal microbiota 
and these approaches include sequencing of cloned 16S rDNA amplicons from 16S rDNA 
library, quantitative real-time PCR, denaturing gradient gel electrophoresis (DGGE), restriction 
fragment length polymorphism (RFLP), terminal restriction fragment length polymorphism 
(T-RFLP), and FISH (Zoetendal, Vaughan et al. 2006). 
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Although 16S rDNA-based approaches have been applied widely in microbial 
ecology, these methods do not provide any clue of the functional potential in an ecosystem, 
particularly with respect to the physiology of uncultivated microbes. A metagenomic approach 
based on genome sequences from an entire community provides a wealth of sequence 
information and has been successfully used to study the phylogenetic, physical and functional 
properties of the microbiome (Zoetendal, Vaughan et al. 2006). Metagenomic approaches have 
been used to examine gut microbiomes in humans (Vacharaksa and Finlay 2010) and animals 
(Walter, Mangold et al. 2005). These recent studies demonstrate that metagenomic approaches 
are promising for unraveling the significance and functionality of gut microbiota and 
information from metagenomic analysis will facilitate our development of novel strategies to 
improve gut health. Notably, Sommer et al. (2009) characterized the AR gene reservoir in 
human gut microflora using metagenomic-based functional cloning method. They identified a 
large number of novel AR genes failed to be discovered in the culture-dependent studies in the 
past. Their results renewed our understanding of the gut microflora; it is an underexplored 
microbiota with even larger genetic diversity than we might have estimated. 
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INTRODUCTION 
 
Zoonotic bacterial pathogens are not only a major cause of diseases in animals but 
may be transmitted to humans, threatening food safety and public health (Taylor, Latham et al. 
2001; Woolhouse and Gowtage-Sequeria 2005; Wolfe, Dunavan et al. 2007). For example, it 
has been widely accepted that many human bacterial pathogens, such as E. coli O157:H7, 
Salmonella, Campylobacter, and Yersinia are transmitted from various food animals such as 
chicken, swine, and cattle (CDC 2010). Antibiotics have been used widely in food animals for 
the purpose of disease prevention and control as well as for growth promotion (van den 
Bogaard and Stobberingh 1999; Gyles 2008). Increasing evidence indicates that antimicrobial 
use in animals selects for resistant bacteria including those that could be transmitted to humans, 
greatly compromising the effectiveness of antibiotic treatments of these pathogens. Therefore, 
examination of mechanisms of antibiotic resistance (AR) development and transmission in 
zoonotic bacteria has a significant impact on animal health and human health.   
Genes involved in AR can be transferred horizontally between diverse bacteria, such 
as from gut normal microflora to pathogens (Witte 2000). Thus, intestinal microflora, which 
contains more than 1,000 different species with total population up to 100 trillion 
microorganisms in human, play a significant role in AR development and transmission. There 
is increasing interest in elucidating the reservoir of gut AR genes that may be horizontally 
transferred to clinically relevant pathogens. In particular, bacteria in the gut are generally 
densely packed, which enhances the efficiency of transformation and conjugation for 
horizontal gene transfer (Marshall 2009). However, the majority of intestinal microflora cannot 
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be cultivated using traditional culturing methods, greatly impeding our understanding of the 
AR gene reservoir in gut microflora. Recently, Sommer et al. (2009) used a 
culture-independent method in conjunction with a functional cloning approach to examine the 
AR gene reservoir in human gut microflora. Strikingly, many AR genes identified by the 
functional cloning shared very low similarity to the known AR genes, indicating these genes 
are novel and the immense diversity of AR genes in the human microflora may contribute to 
future emergence of antibiotic resistance in human pathogens.   
  Based on this recent finding in the human gut microflora, we hypothesize that the 
gut microflora in food animals also contains diverse and novel AR gene reservoir, which plays 
an important role in the emergence of AR pathogens. Notably, given that many prevalent 
human foodborne pathogens, such as E. coli O157:H7, Salmonella, and Campylobacter, are 
from the intestinal tract of food animals, the gut microflora in food animals should also serve 
as a significant AR gene pools for AR human pathogens. Despite its significant impact on 
animal health and public health, the AR gene reservoir in gut microflora of food animals is still 
largely unknown.  
  Using total genomic DNA extracted from chicken cecal contents and an efficient E. 
coli expression vector pZE21-MCS (Lutz and Bujard 1997), in this study, we constructed four 
metagenomic libraries for functional screening of AR genes against six antibiotics that 
represent five major classes of antibiotics. We identified novel AR genes from gut microflora 
in both free range and conventionally raised chickens. In addition, an E. coli-Campylobacter 
shuttle vector pZW bearing a flaA promoter (sigma 28) was constructed. The identified novel 
AR genes (FRAmp1.1 and FRSpe1.1) were cloned successfully into this shuttle vector and 
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demonstrated to confer increased resistance to corresponding antibiotics in C. jejuni, an 
important foodborne bacterial pathogen with chicken as a major animal host. 
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MATERIALS AND METHODS 
Bacterial strains, plasmids, and culture conditions  
The major bacterial strains and plasmids used in this study are listed in Table 1. 
Campylobacter strains were grown routinely in Mueller-Hinton (MH) broth (Difco, Sparks, 
MD) or on agar at 42
o
C under microaerobic conditions, which were generated using a 
CampyGen Plus (Oxoid, Hampshire, England) gas pack in an enclosed jar. Escherichia coli 
was grown in Luria-Bertani (LB) broth with shaking (250 rpm) or on agar at 37 
o
C overnight. 
 
Extraction of total genomic DNA from chicken cecal content  
Total genomic DNAs from cecal contents of two free-range chickens (kindly 
provided by Mr. Wade Wisner, Dandridge, TN) and two conventionally raised chickens (from 
KOCH Foods, Inc., Morristown, TN) were extracted separately using the PowerMax Soil DNA 
Isolation Kit (Mobio Laboratories Inc.) with minor modifications. Briefly, 5 g of cecal content 
from each individual chicken were used for extraction. Cell lysis mix was treated by incubation 
in 65
o
C water bath for 5 min, followed by 5 min vortexing; this procedure was repeated one 
time. A total 5 ml of the elution buffer (Solution C6, TE buffer, pH 8.0) was used to elute pure 
DNA bound to the provided column. As a control for comparison of DNA yield and quality, 
the total DNA was also extracted from ileal contents of free-range chickens. The DNA 
concentration and ratio of absorbance at 260 nm and 280 nm were measured using NanoDrop 
Spectrophotometer (Thermo Scientific).  
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Construction of metagenomic libraries 
Genomic DNAs obtained from four individual chickens were concentrated to about 30 
ng/μl by Vacufuge concentrator (Eppendorf) and sheared physically to fragment size about 
3,000 base pairs (The shearing service was provided by Covaris Inc.). The fragment size was 
determined by running on 0.8% EB stained agarose gel together with 1kb DNA ladder for 40 
min at 80 volts in 1x TAE buffer. Gel slices corresponding to fragments in a size ranging from 
1,000 to 4,000 bp were excised and the DNAs were extracted from the gel slice using 
QIAquick® Gel extraction kit (Qiagen). Extracted fragments were then blunt-ended by using 
the End-it® end repair kit (Epicentre). End-repaired fragments were subsequently purified 
from the reaction mix by using QIAquick PCR purification kit (Qiagen) for ligation described 
below. 
The expression plasmid vector pZE21-MCS (Lutz and Bujard 1997) was digested by 
HincII (Promega). Linearized vector DNA was visualized by 0.8% agarose gel. The 
HincII-digested, linearized vector was extracted from the gel slice using QIAquick® Gel 
extraction kit (Qiagen).The linearized vector DNA was then dephosphorylated using 
Promega® Alkaline Phosphatase Calf Intestinal (HC), which was further purified using 
QIAquick PCR purification kit (Qiagen). 
Both the above end-repaired DNA fragments and linearized vector DNA were 
concentrated to a final concentration of 250 ng/μ l. The end-repaired DNA fragment from each 
individual chicken was ligated to HincII-digested pZE21-MCS using Fast-Link® ligation kit 
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(Epicentre) in a reaction mix containing 4μ l of vector DNA, 12μ l of sheared DNA, 2 μ l of 
Fast-Link buffer, 1 μ l of ATP solution, and 1μ l of T4 ligase. The ligation mix was incubated 
overnight at room temperature (25 
o
C) prior to use. 
A total 2μ l of the above ligation mix was used to electroporate 50 μ l of 
ONE-SHOT
® 
TOP10 Electrocompetent cells (Epicentre). Electroporation was conducted using 
MicroPulser Electroporation system (Bio-Rad) using pre-programmed setting Ec1 (for E. coli 
in 0.1 cm cuvette, 1.8kV, 1 pulse). Cells were then recovered in 1 ml of SOC medium by 
shaking at 250 rpm for 1 hr at 37 °C. 
For each transformation mix, 10 μ l of the recovered cells were used for determining 
the library size. Cells were serially diluted in LB broth and plated on LB agar plates containing 
50μ g/ml of kanamycin for determination of total colony forming units (CFUs) of the 1ml 
recovered cells. The size of the library was then estimated by multiplying the total CFU of 
recovered cells and the average size of the inserted fragment. The rest of the transformation 
mixes were inoculated into 10ml LB broth supplemented with 50 μg/ml of kanamycin and 
grown overnight at 37 
o
C. Overnight cultures were mixed with glycerol (final concentration of 
15%), and stored in 5-ml aliquots at -80 
o
C prior to screening. If needed, the 5-ml aliquot was 
inoculated into 20 ml LB broth with 50 μg/ml of kanamycin and grown overnight to maintain 
the library. 
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Screening and characterization of AR genes 
Approximately 150 μ l of stored culture from each library were spread on a single 
LB agar plate containing 50 ug/ml of kanamycin combined with the antibiotic of interest at 
theappropriate concentration (Table 3), which is equal to 2× the minimum inhibitory 
concentration (MIC) of TOP10 containing empty vector pZE21-MCS for the corresponding 
antibiotic. A total of 3-15 ml of stored culture from each library was used for screening 
transformants with resistance to a specific selected antibiotic. Plates were incubated at 37 °C 
for 16 hrs. 
Colonies grown on agar plates containing combined antibiotics were selected 
randomly and inoculated into 5ml of LB broth supplemented with the same combination of two 
antibiotics. The culture was grown overnight and the plasmid was extracted from the culture 
using QIAprep
® 
spin miniprep kit (Qiagen). The inserted fragment in the plasmid was then 
sequenced bidirectionally using primers pZE-F and pZE-R (Table 2). Plasmids from 
false-positive colonies (no insertion) and plasmids from the potential redundant colonies (same 
size of insertion within a library) were not subjected to sequencing. 
To analyze the sequence, the open reading frame (ORF) of each inserted fragment 
was identified using ORFfinder (www.ncbi.nlm.nih.gov/projects/gorf/). Identified ORFs were 
compared to Genbank database using tblastx, which computes alignment based on the amino 
acid sequence of the gene, translated in all 6 frames. For each query, the gene of the top 
scoring hit in the database was recorded for their origin, annotation, and percentage sequential 
similarity.  
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Construction of E. coli-Campylobacter shuttle vector bearing a strong Campylobacter 
promoter  
An E. coli-Campylobacter shuttle vector carrying a strong Campylobacter promoter 
was constructed according to the procedure described by Larsen et al. (2004). Briefly, the 
sigma 28 promoter of the flaA gene was PCR amplified from genomic DNA of C. jejuni 
NCTC 11168 (Tabel 1) using the primer pair Sig28-F/Sig28-R (Table 2). PCR reaction mix 
was prepared by mixing 1 μl of each primer (5 pmol/ml), 1 μl of template genomic DNA (50 
ng/μl), 14.5 μl of ddH2O and 17.5 μl of 2x GoTaq PCR mix into a total volume of 25 μl. The 
templates and primers were denaturized at 95°C for 180 seconds. Then a 3-step PCR was 
performed with 30 cycles of denaturation at 95°C for 30 seconds, annealing at 55°C for 45 
seconds, and extension at 72°C for 30 seconds, followed by a final extension at 72°C for 90 
seconds. The PCR product was purified and digested by BamHI and XbaI (Promega), followed 
by ligation to the pRY111 vector that was digested with the same enzymes. Five μl of the 
ligation mix was then applied to 50μl of ice-cold E. coli DH5α chemical competent cells. The 
mixture was put on ice for 35 minutes before being heat shocked at 42 °C for 30 seconds. The 
mixture was then put on ice for 2 minutes, mixed with 500 μl SOC medium and shaked for 1 
hour at 37 °C and 250 rpm. The transformation mix was spread on LB agar plates 
supplemented with 20 μg/ml of chloramphenicol and grown for 16 hours at 37 °C. Colonies 
were randomly picked and inoculated into 5 ml LB broth with 20 μg/ml chloramphenicol and 
grown overnight. The plasmids were extracted by using QIAprep® spin miniprep kit (Qiagen) 
according to the recommended procedure, and the correct recombinant plasmids were 
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determined by PCR amplification of the inserted sigma 28 promoter sequence. The plasmid 
containing the desired sigma 28 promoter was designated as pZW and the E. coli DH5α 
transformed with pZW was named JL850 (Table 1). 
 
Cloning and expression of selected AR genes in C. jejuni 81-176.  
To determine if the identified novel AR genes are functional in Campylobacter, two 
of the novel AR genes (FRAmp1.1 and FRSpe1.1) were cloned into the newly constructed 
expression vector pZW. The kanamycin resistance gene KAN-2 served as a positive control 
because this gene was from EZ::TN <KAN-2> Transposon and was functional in 
Campylobacter (Lin, Wang et al. 2009).  
Promoterless KAN-2 gene was PCR amplified from genomic DNA of a mutant with 
EZ::TN <KAN-2> Transposon insertion (Lin, Wang et al. 2009) using primer pair CKn-F and 
CKn-R (Table 2). The amplified fragment was digested by BamHI and XbaI (Promega) for 
directional coloning. The digested fragment was ligated into the pZW digested with the same 
restriction enzymes. The ligation mix was used to transform E. coli DH5α for selection of 
chloramphenicol resistant transformants. Plasmids from the selected transformants were 
extracted and the recombinant plasmid containing desired KAN-2 gene was determined by PCR 
amplification of the plasmid using primer pair CKn-F and CKn-R (Table 2). The pZW 
containing a KAN-2 gene that was inserted downstream of sigma 28 promoter was named 
pZW3 (Table 1).  
Promoterless FRAmp1.1 and FRSpe1.1 were PCR amplified from plasmids 
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pZE21-MCS-FRAmp1.1 and pZE21-MCS-FRSpe1.1 (Table 1), respectively, using primers 
pairs Cam-BamHIF/Cam-EcoRIR for FRAmp1.1 and CSp-BamHIF/CSp-EcoRIR for FRSpe1.1 
(Table 2). PCR, ligation and transformation were the same as above for constructing pZW3. 
The new plasmids pZW1 and pZW2 were generated, in which the novel FRAmp1.1 and 
FRSpe1.1 genes were inserted downstream of sigma 28 promoter in pZW, respectively.  
To conjugatively transfer the above plasmids into C. jejuni 81-176 (JL242, Table 1), 
JL48 was used as the helper strain and the new construct JL850, JL851, JL852, or JL853 
(Table 1) was used as donor strain for conjugation as described previously (Zeng, Xu et al. 
2009). Briefly, late log-phase of C. jejuni 81-176 was spread onto MH agar and grown 
overnight. Then C. jejuni cells were harvested and resuspended in MH broth to an optical 
density of 1.0 at 600 nm (OD600). Both donor strain and helper strain were grown in LB to an 
OD600 of approximate 1.0. Three types of cells were mixed at a ratio of 1:1:10 
(donor/helper/recipient), resuspended in 100 μl MH broth and spotted onto MH agar plates. 
The plates were incubated for 5 hours at 42°C under microaerophilic conditions. The mating 
spots were then resuspended in MH broth and plated onto MH agar supplemented with 20 
μg/ml chloramphenicol, 1 μg/ml polymyxin B and 10 μg/ml trimethoprim for selection of 
desired C. jejuni transformants. Plates were examined after 3 days of incubation and the 
colonies were randomly picked for confirming the presence of the desired recombinant plasmid. 
The resulting C. jejuni strains were referred to as JL854 (JL242 with pZW), JL855 (JL242 with 
pZW1), JL856 (JL242 with pZW2) and JL857 (JL242 with pZW3) (Table 1).  
Susceptibility of JL854, JL855, JL856, and JL857 to ampicillin, kanamycin and 
spectinomycin were determined by a standard microtiter broth dilution method with an inocula 
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of 10
6
 bacterial cells/ml as described previously (Lin, Michel et al. 2002). Minimum inhibitory 
concentrations (MICs) were determined by the lowest concentration of specific antibiotic 
showing complete inhibition of bacterial growth after two days of incubation at 42
0
C.   
 
Generation of a phylogenetic tree for different beta-lactamases.  
Phylogenetic analysis of FRAmp1.1 was performed together with 25 presently 
identified beta-lactamases representing 21 different families. Amino acid sequences were 
aligned in ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) using the GONNET 
proteinweight matrix. Unrooted phylogenetic trees were generated from ClustalW2 alignments, 
using the neighbor‐joining algorithm based on the principle of minimum evolution. Tree 
branch lengths are proportional to relative sequence identity, and the scale bar was in fixed 
amino acid substitutions per sequence position. Pairwise scores were calculated as the number 
of identities in the best alignment divided by the number of residues compared. 
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RESULTS 
High-quality genomic DNA was extracted from chicken fecal samples.  
Total genomic DNA was successfully extracted from fecal samples of two free range 
chickens and two conventionally raised chickens (FIG. 1A). For free range chickens, 5 ml of 
genomic DNA with a concentration about 24 ng/μl were obtained from 5 g of each cecal 
sample; the A260/A280 of both samples was about 1.70. However, the yield (2.0 ng/μl) and 
purity (A260/A280 = 1.34) of the DNA extracted from the ileal content were lower than those 
from cecal content (Fig. 1A). For conventionally raised chickens, 5 ml of genomic DNA were 
obtained from two 5g cecal samples with a final concentration of 52.3 ng/μl and 99.5 ng/μl, 
respectively. The A260/A280 ratio of the two DNA samples were 1.83 and 1.93.  
 
Construction of the metagenomic libraries 
Cecal genomic DNA (Fig. 1A) was sheared to small fragments ranging from 1,000 to 
4,000 bp (Fig. 1B). Four libraries corresponding to cecal content samples from two free-range 
chickens and two conventionally raised chickens were successfully constructed. The randomly 
selected transformants contained plasmids bearing the inserted fragment, leading to increased 
plasmid size as compared to parent plasmid pZE21-MCS (FIG. 1C). Libraries were hereafter 
referred to as FR1 (from #1 Free Range chicken), FR2 (from #2 Free Range chicken), CR1 
(from #1 Conventionally Raised chicken) and CR2 (from #2 Conventionally Raised chicken). 
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The total number of transformants obtained in the 1 ml SOC recovered cell culture was 
2.0×10
4
 for FR1, 7.0×10
4 
for FR2, 1.2×10
5
 for CR1 and 8.0×10
4
 for CR2. Given the average 
fragment size estimated to be 2,000 bp (Fig. 1B), the total sizes of each of the four 
metagenomic libraries ranged from 0.4×10
8
 to 2.4×10
8
 bp.  
 
Screening AR genes from the metagenomic libraries 
Colonies grew on ampicillin-containing agar plates for cultures from all four libraries 
(Table 4). In terms of tetracycline, only cultures from library CR2 contained 
tetracycline-resistant transformants. The chloramphenicol-resistant colonies were observed 
only from libraries CR1 and CR2 while spectinomycin-resistant colonies were observed only 
from libraries FR1 and CR2 (Table 4). No single resistant colony was selected on the plates 
supplemented with norfloxacin or ciprofloxacin from any of the four libraries (Table 4). The 
AR colonies were randomly picked for plasmid extraction (the number of colonies picked from 
each library for all six antibiotics is listed in Table 4), and the successful insertion of fragments 
was confirmed by gel electrophoresis as shown in FIG. 1C. Inserted fragments in plasmids 
from selected clones were then sequenced bidirectionally (number of clones subjected for 
sequencing is listed in Table 5).  
ORF was identified from the inserted sequence and compared to the sequence 
available in public database in Genbank (http://www.ncbi.nlm.nih.gov/genbank/). A total of 15 
AR genes were identified from the four libraries with 3 from two free-range chicken libraries 
(Table 6) and 12 from conventionally raised chicken libraries (Table 7). Among the 15 
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identified genes, 8 shared low sequence similarities (58% - 76% at amino acid level) with the 
corresponding AR genes previously identified using culture-dependent approaches (Table 6 & 
7). Notably, among the 8 novel genes, 4 were unique in this study, which shared low sequence 
similarities (59% - 76% at amino acid level) with recently identified novel AR genes in human 
gut (Sommer, 2009) (Table 6 & 7).  
Each gene identified in this study was named with a two letter code corresponding to 
the source (FR – Free-Range chickens and CR – Conventionally Raised chickens) followed by 
a three letter code referring to the three initial letter of the antibiotic used for screening 
(Amp-ampicillin, Spe-spectinomycin, Chl-chloramphenicol, Tet-tetracycline), and then the 
digit corresponding to the number of the library (1 or 2 for free range chickens and 1 or 2 for 
conventionally raised chickens), and a final digit used to distinguish each unique gene against 
the specific antibiotic and from the specific chicken. 
 
FRAmp1.1 was distantly related with identified beta-lactamases.  
Phylogenetic analysis of different beta-lactamases showed high divergence between 
amino acid sequences of beta-lactamase from different groups (FIG. 2). The beta-lactamases 
identified by metagenomic-based functional cloning from the gut microflora, including 
FRAmp1.1 identified in this study, showed high divergence and tended to branch off early 
from the ancestor, while the common beta-lactamase groups well-characterized by 
culture-dependent methodologies were grouped into a major cluster (FIG. 2). The pairwise 
scores for all sequences range from 1.0 to 100.0 (the higher pairwise score the closer 
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evolutionary relationship; lower pairwise score the more distant phylogenetic relationship). 
Specifically, FRAmp1.1 was distantly related to all the beta-lactamases identified from human 
gut microflora (Sommer et al. 2009) using functional metagenomics (pairwise scores ranging 
from 4.0 to 36.0) (FIG. 2). In addition, FRAmp1.1 was also distantly related with all the 
well-characterized beta-lactamases in cultivated microorganisms, regardless of their particular 
origin (pairwise scores ranging from 2.0 to 34.0) (FIG. 2). Notably, FRAmp1.1 was very 
distantly related with the beta-lactamases characterized in Campylobacter (pairwise scores 
equal to 2.0).  
 
The identified novel AR genes confer increased resistance in C. jejuni.  
The expression vector pZW that was functional in C. jejuni was constructed correctly, 
which was confirmed by PCR amplification of the inserted flaA promoter (Fig 3A). Plasmids 
containing control KAN-2 gene and two novel AR genes (FRAmp1.1 and FRSpe1.1) were also 
successfully constructed using pZW as a parent plasmid; the correct insertion of desired AR 
gene was also confirmed by PCR amplification (FIG. 3B). All the new plasmids were 
conjugatively transferred into C. jejuni 81-176, generating strains JL854, JL855, JL856, and 
JL857 (Table 1). 
Antibiotic susceptibility test showed that JL857 (C. jejuni 81-176 with a KAN-2 
containing plasmid) displayed a dramatically enhanced resistance to kanamycin (MIC>128 
μg/ml) compared to the control strain JL854 (MIC=8 μg/ml). This finding strongly indicated 
that the cloned flaA promoter in pZW was functional and the plasmid pZW was an effective 
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expression vector for Campylobacter. When the novel FRAmp1.1 was inserted in the pZW and 
transferred to C. jejuni 81-187, the derivative JL855 displayed  an enhanced resistance to 
ampicillin (MIC=8 μg/ml) compared to control strain JL854 (MIC=1 μg/ml). Similarly, JL856, 
the strain containing plasmid bearing FRSpe1.1 gene showed enhanced resistance to 
spectinomycin (MIC=32 μg/ml) compared to control strain JL854 (spectinomycin MIC= 8 
μg/ml).  
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DISCUSSION 
In this study, novel AR genes were identified from the chicken gut microflora using a 
culture-independent functional cloning approach. Similar to what was observed in the human 
gut microflora (Sommer, 2009), novel AR genes constitute a substantial proportion (8 of 15) of 
all AR genes identified in this study. This confirmed our hypothesis that the animal gut 
microflora contains a large and diverse AR gene reservoir. Previous conventional 
culture-dependent work may only reveal a small subset of AR genes, leaving the majority 
underexplored. Notably, this study was the first to demonstrate that the selected novel AR 
genes can be expressed in C. jejuni, consequently leading to enhanced antibiotic resistance in 
this significant foodborne human pathogen. This finding suggests that these novel AR genes, 
although highly divergent from previously identified AR genes using culture-dependent 
approaches, are indeed utilizable by important zoonotic pathogens and may pose a significant 
threat to public health. 
The likelihood of identification of AR genes using the metagenomic-based functional 
cloning method is primarily affected by following two factors. First, the abundance of 
particular AR genes in the gut microflora will define their probability to be identified. The 
particular subsets of AR genes may be selected and enriched due to selective pressure through 
the usage of specific antibiotics (van den Bogaard 1997). In accord with this, in this study we 
identified more AR genes from conventionally raised chickens that were exposed to antibiotics 
than those from free-range chickens that were never treated with antibiotics. The number of 
AR genes identified in human gut microflora (Sommer et al. 2009) was also larger than what 
we identified in free range chicken gut microflora in this study, which could be due to the 
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selective effect of antibiotic usage in humans. Although the human subjects from whom feces 
were sampled (Sommer et al. ,2009) had not been treated by antimicrobial drugs in the past 
one year prior to sampling, the selected AR flora may be “resistant to elimination” (Salyers and 
Amabile-Cuevas 1997). As a result, it was questionable to which extent the reshaping affect of 
earlier antibiotic treatment on gut microflora could be eliminated in one year. Second, besides 
the abundance of AR genes in the reservoir, the size of the library is also a limiting factor of 
the likelihood of identifying AR genes. Each of our metagenomic libraries, which has a size 
about 10
8
 bp covered only a small proportion of the metagenome of the gut microflora (Qin, Li 
et al. 2010). The difference in size of the libraries used in the human study (~10
9
 bp per library) 
(Sommer et al. 2009) and in this study (~10
8
 bp per library) may explain the difference 
between the number of AR genes identified from the two sources (90 for human, 12 for 
conventionally raised chickens). 
The AR genes identified in this study encode beta-lactamases, aminoglycoside 
adenylyltransferases, ribosome protection proteins, and chloramphenicol acetyltransferases. 
Notably, among the 15 AR genes identified in this study, 4 genes are novel and displayed low 
similarity to AR genes discovered either using culture-dependent methodologies or using 
similar culture-independent approach for human gut microflora (Sommer et al. 2009). These 
four genes include one beta-lactamase, two spectinomycin adenylyltransferase and one 
chloramphenicol acetyltransferase. Specifically, a phylogenetic tree was constructed to analyze 
phylogenetic relationship of the novel beta-lactamase identified in this study (FRAmp1.1) to 
other diverse beta-lactamases identified to date. The FRAmp1.1 was distantly related with all 
the other beta-lactamases included in the analysis including isolates from human and animal 
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commensals (FIG. 2). Considering the fact that our library only covered a small proportion of 
the whole metagenome in chicken gut microflora, it is reasonable to speculate that more AR 
genes are harbored by the animal gut microflora that are not present in human gut microflora. 
These “heterologous” AR genes could pose a potential threat to public health because it is 
possible that, after transmission to zoonotic human pathogens, they can confer resistance 
against antimicrobial drugs commonly applied to human patients, thus compromising 
effectiveness of clinical antibiotic usage  
Horizontal gene transfer (HGT) that facilitates the spreading of AR genes has three 
major mechanisms including transfection, transformation, and conjugation. Because HGT 
occurs more frequently in densely packed cells like commensal bacteria in the intestinal tract 
(Marshall 2009), novel AR genes harbored by animal gut microflora have the potential to be 
transmitted into zoonotic pathogens through HGT. As a result, it is of concern if these novel 
AR genes can function in zoonotic pathogens when HGT actually happens. In this study, we 
tested the functionality of two sequentially novel AR genes (FRAmp1.1 conferring ampicillin 
resistance and FRSpe1.1 conferring spectinomycin resistance) in the zoonotic human pathogen 
C. jejuni. Concerning sequential difference, the two selected genes shared low sequential 
similarity to the major determinants of ampicillin resistance (Cj0229) (Griggs, Peake et al. 
2009) and spectinomycin resistance (AadE) (Pinto-Alphandary, Mabilat et al. 1990) in 
Campylobacter. The Cj0229 and all other beta-lactamases identified in Campylobacter are the 
most distantly related with FRAmp1.1 among all the beta-lactamases used for phylogenetic 
analysis (FIG 2). With respect to FRSpe1.1, this putative adenylyltransferase shared only 67% 
similarity at the amino acid level with O6-adenylyltransferase AadE. Despite their significant 
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sequence difference with the identified AR gene products in Campylobacter, both FRAmp1.1 
and FRSpe1.1 could express in Campylobacter and confer increased resistance to ampicillin 
and spectinomycin, respectively. The successful function of both AR genes demonstrated in 
this study strongly supports the concept that, if successfully transferred into a zoonotic 
pathogen, the novel AR genes may be expressed and subsequently confer enhanced AR 
resistance in the pathogen. This may pose a significant challenge for antibiotic therapy and 
diagnosis of antibiotic resistance. Particularly, because the resistance phenotype and spectrum 
of the novel AR genes are still largely unknown, we should be aware of the possibility that 
antibiotics presently used may become ineffective when novel AR genes are acquired by 
pathogens.    
Characterization of novel AR genes from animal microbiota is important in several 
ways. First, the sequentially divergent genes can help to assemble a more complete image of 
the evolutionary history of AR genes. Second, further functional and structural study of novel 
AR genes would improve our understanding of the relationship between sequence diversity and 
the spectrum and level of resistance (Wolter, Kurpiel et al. 2009). Third, since the selected 
novel AR genes can express and function in zoonotic pathogens, thorough examination of 
novel AR genes in food animals and even other agriculture systems (e.g. manure management) 
will greatly enhance the power of molecular diagnostic tools for AR in zoonotic pathogens 
(Shamputa, Rigouts et al. 2004) and provide insights into the development and transmission of 
AR. Finally, considering the fact that genes for antibiotic biosynthesis were sometimes 
clustered with AR genes, identification of novel AR genes may lead to discovery of potentially 
novel antibiotics (Riesenfeld, Goodman et al. 2004).  
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In this study, a culture-independent functional cloning approach was used to identify 
AR genes in the gut microflora of both free-range and conventionally raised chickens. Despite 
the significant findings from this study, following limitations should be addressed for future 
large-scale identification of AR genes using a similar approach. First, restricted by the 
efficiency of molecular cloning, the size of the libraries constructed in this study was not large 
enough to cover genetic diversity of the whole gut microbial community. Thus, improving 
cloning efficiency would greatly increase library size and provide a greater chance to identify 
more novel AR genes. For instance, Shrimp Alkaline Phosphatase (SAP) may be used as an 
alternative to Calf Intestinal Alkaline Phosphatase (CIAP) to dephosphorylate the cloning 
vector, since it can be easily inactivated and will less likely affect downstream cloning 
procedures. Second, samples from four chickens may be inadequate to infer correlations 
between the uses of antibiotics with the change of prevalence and abundance of AR genes. On 
one hand, the antibiotics used in poultry were not uniform (Gyles 2008). Results from a small 
subset of chickens are not suitable to be used to draw solid conclusions regarding the 
relationship between antibiotic usage and profiles of AR reservoir in the gut. On the other hand, 
the effects of antibiotics on microbial communities are complex. Besides direct selection of 
corresponding AR strains, antibiotics may also affect the microbiota indirectly, or even 
function as signaling molecules that further complicate the system (Yim, Wang et al. 2007). 
More chickens treated with different combinations of antibiotics need to be sampled to better 
elucidate the consequences of the application of particular antibiotics on the emergence of AR 
genes in the chicken gut microflora. Finally, as a pilot study, we only used chickens as a model 
to analyze gut AR reservoir in this work. As mentioned above, the functional cloning method 
can be extended into the investigation of AR gene reservoir in other habitats, including gut 
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microbiota in other food animals, microbiota in other parts of the animal body, and microbiota 
in other targeted ecosystems of agriculture, such as soil, water, lagoon, etc. Similar functional 
cloning approaches have been used to identify specific AR genes, and these studies further 
demonstrated the power of the methodology in revealing natural AR gene reservoir that may 
exhibit much  higher level of diversity than previously expected (Riesenfeld, Goodman et al. 
2004; Allen, Moe et al. 2009; Donato, Moe et al. 2010).  
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Table 1. Bacterial strains and plasmids used in this study. 
Strain or Plasmid Description Source 
 
 
 
E.coli 
 
DH5α E.coli, F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 
endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 
relA1 
Invitrogen 
TOP10 E.coli, F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ(ara leu) 7697 galU galK rpsL 
(StrR) endA1 nupG 
Invitrogen 
JL519 DH5α containing pZE21-MCS This study 
JL48 Conjugation helper strain, DH5α containing pRK2013 (Zeng, Xu 
et al. 2009) 
JL860 Top10 containing pZE21-MCS- FRAmp1.1 This study 
JL861 Top10 containing pZE21-MCS- FRSpe1.1 This study 
JL850 DH5α containing pZW This study 
JL851 DH5α containing pZW1 This study 
JL852 DH5α containing pZW2 This study 
JL853 DH5α containing pZW3 This study 
 
 
C. jejuni 
 
JL241 NCTC 11168, human isolate (Parkhill, 
Wren et al. 
2000) 
JL242 C. jejuni 81-176, human isolate (Black et 
al. 1988) 
JL854 JL242 containing pZW This study 
JL855 JL242 containing pZW1 This study 
JL856 JL242 containing pZW2 This study 
JL857 JL242 containing pZW3 This study 
 
 
Plasmids 
 
pZE21-MCS Cloning and expression vector, Kan
r
 Lutz 1997 
pRY111 E. coli-C. jejuni shuttle vector, Cm
r
 (Yao, Alm 
et al. 1993) 
pRK2013 a helper plasmid for triparental mating (Miller, 
Bates et al. 
2000) 
pZE21-MCS- 
FRAmp1.1 
pZE21-MCS with metagenomic fragment containing 
FRAmp1.1 
This study 
pZE21-MCS- 
FRSpe1.1 
pZE21-MCS with metagenomic fragment containing 
FRSpe1.1 
This study 
pZW pRY111 containing flaA promoter This study 
pZW1 pZW containing ampicillin resistant gene FRAmp1.1 This study 
pZW2 pZW containing spectinomycin resistant gene FRSpe1.1 This study 
pZW3 pZW containing kanamycin resistant gene KAN-2 This study 
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Table 2. PCR primers used in this study. 
Name Sequence 
pZE-F 
pZE-R 
5‟-GAA TTC ATT AAA GAG GAG AAA GGT-3‟ 
5‟-TTT CGT TTT ATT TGA TGC CTC TAG-3‟ 
Sig28-F 
Sig28-R 
5‟-GCT CTA GAG CGT AAA ATT GAA GAT GAA AGA GAG-3‟(XbaI)* 
5‟-CGG GAT CCC GTT TTA AAT CCT TTT AAA TAA TTT C-3‟(BamHI) 
CAm-BamHIF 
CAm-EcoRIR 
5‟-CGG GAT CCC ATC GCA AGT GAA ATG ACA TCA GTA 
C-3‟(BamHI) 
5‟-CGG AAT TCC TCC TTA ACT CCT AAA ATT TAA CTT C-3‟(EcoRI) 
CSp-BamHIF 
CSp-EcoRIR 
5‟-CGG GAT CCC CCG AAT GTG AAT ATA TGT AC-3‟(BamHI) 
5‟-CGG AAT TCC ATT TTA AGC AAA ACT TTA CAG CC-3‟(EcoRI) 
CKa-F 
CKa-R 
5‟-CGG GAT CCG TAA TAC AAG GGG TGT TAT G-3‟(BamHI) 
5‟-CGG AAT TCA TTA GAA AAA CTC ATC GAG C-3‟(EcoRI) 
 
*: Restriction sites are underlined in the primer sequences and the corresponding names are in 
parentheses. 
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Table 3. Antibiotics used for functional screening. 
Antibiotic Concentration (μg/ml) 
Ampicillin 50 
Tetracycline 10 
Chloramphenicol 25 
Spectinomycin 75 
Norfloxacin 12.5 
Ciprofloxacin 10 
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Table 4. Number of colonies selected from various metagenomic libraries for plasmid 
extraction. 
Antibiotic Library
a
 Number of colonies selected for 
plasmid extraction 
 
Ampicillin 
FR1 18 
FR2 12 
CR1 10 
CR2 9 
 
Tetracycline 
 
FR1 0 
FR2 0 
CR1 0 
CR2 14 
 
Chloramphenicol 
FR1 0 
FR2 0 
CR1 2 
CR2 4 
Spectinomycin FR1 7 
FR2 0 
Spectinomycin CR1 0 
CR2 12 
 
a 
FR1: free-range chicken #1; FR2: free-range chicken #2; CR1: conventionally raised chicken 
#1; CR2: conventionally raised chicken #2. 
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Table 5. Number of clones in which plasmids were subjected to sequencing. 
Antibiotic Library Number of clones selected for 
sequencing analysis 
Ampicillin FR1 12 
FR2 6 
CR1 7 
CR2 6 
 
Tetracycline 
 
 
FR1 0 
FR2 0 
CR1 0 
CR2 7 
 
Chloramphenicol 
FR1 0 
FR2 0 
CR1 2 
CR2 2 
Spectinomycin FR1 3 
FR2 0 
Spectinomycin CR1 0 
CR2 5 
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Table 6. Antibiotic resistance genes identified in the cecal contents of free-range chickens. 
Antibiotic 
Gene 
name 
Chicken 
(FR) 
Length 
(bp) 
Annotation: 
% aa 
similarity 
with the 
genes from 
cultivated 
organisims* 
% aa similarity 
with genes from 
metagenomic 
study** 
Ampicillin 
FRAMP1.
1 
1 902 
Beta-lactamas
e 
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FRAMP2.
1 
2 861 
Ampicillin 
resistant gene 
100 - 
Tetracycline - - -  - - 
Chloramphenicol - - -  - - 
Spectinomycin FRSPE1.1 1 459 
Adenylyltrans
ferase 
67 - 
Norfloxacin - - -  - - 
Ciprofloxacin - - -  - - 
 
-: No genes identified or parameter not available. 
*: similarity comparing with the AR genes discovered in studies using culture-dependent approach. 
**: similarity comparing with the AR genes discovered by Sommer et al. (2009) using the same 
culture-independent, functional cloning approach. 
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Table 7. Antibiotic resistance genes identified in the cecal contents of conventionally raised 
chickens. 
Antibiotic Gene 
name 
Chicken 
(CR) 
Length 
(bp) 
Annotation
: 
% aa 
similarity 
with the 
genes from 
cultivated 
organisms* 
% aa similarity 
with genes from 
metagenomic 
study** 
Ampicillin CRAMP1.
1 
1 345 TEM 98  
CRAMP1.
3 
1 525 TEM 91 - 
CRAMP2.
1 
2 513 CbIA 58 100 
CRAMP2.
2 
2 642 HGF-1 63 99 
CRAMP2.
3 
2 510 CbIA 67 98 
CRAMP1.
4 
1 861 TEM 100 - 
CRAMP1.
5 
1 423 Drug efflux 
transporter 
77 97 
Tetracycline CRTET2.
1 
2 936 Tetw 99 - 
CRTET2.
2 
2 660 Tetw 99 - 
Chloramphenicol 
 
CRCHL2.
1 
1 804 CAT 92 - 
CRCHL2.
2 
1 639 CAT 76 - 
Spectinomycin CRSPE2.1 2 774 Adenylyl 
transferase 
99 - 
Norfloxacin - - - - - - 
Ciprofloxacin - - - - - - 
 
-: No genes identified or parameter not available. 
*: similarity comparing with the AR genes discovered in studies using culture-dependent methodology. 
**: similarity comparing with the AR genes discovered by Sommer et al. (2009) using the same 
culture-independent, functional cloning approach.
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FIG. 1. Extraction, shearing and cloning metagenomic DNA into the expression vector 
pZE21-MCS. (A) Extraction of total genomic DNAs from chicken fecal contents. Lane M, 1kb 
DNA ladder (Promega); Lane 1, 5 μl of extracted DNA from ileal content of a free range 
chicken; Lane 2, 5 μl of extracted DNA from cecal content of a free range chicken B) Shearing 
of the extracted genomic DNA from cecal contents. Lane M, 1kb DNA ladder (Promega); Lane 
1 and 2, 7 μl of sheared genomic DNAs of cecal samples from two different conventionally 
raised chickens; (C) Cloning of sheared metagenomic DNA fragments into pZE21-MCS. Lane 
M, 1kb DNA ladder (Promega); Lane 0, 5 μl of pZE21-MCS; Lane 1-6, 5 μl of plasmids 
extracted from different transformants randomly selected from one library.  
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     FIG. 2. Phylogenetic relationship of beta-lactamases from different sources. Unrooted 
phylogenetic trees were generated from ClustalW2 alignments using the neighbor-joining algorithm. 
FRAmp1.1 discovered in this study was analyzed together with 25 identified beta-lactamases. *: the 
beta-lactamases representing the novel beta-lactamase families (HOA and HGA, HGB, HGC, HGD, 
HGE, HGF, HGG, HGH, HGI) discovered by Sommer et al. using culture-independent approach (2009); 
**: the beta-lactamases discovered by Sommer et al. (2009) representing previously characterized 
beta-lactamase families (TEM, CfxA, CblA, CTX-M, two for AmpC); ***: the beta-lactamases 
representing previously characterized common beta-lactamase families not analyzed by Sommer et al 
(2009) [SHV (Veras, Alves et al. 2011), OXA-10 (Huang), IMP (Osano, Arakawa et al. 1994), VIM 
(Lauretti, Riccio et al. 1999), KPC (Yigit, Queenan et al. 2001)]; ****: the beta-lactamases identified in 
different Campylobacter jejuni strains, which include Cj0299 (Accession # YP_002343737), CJE0344 
(Accession# AAW34933), CJS3_0285 (Accession # ADT72049), and Cam1 (Accession #AAT01092).  
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FIG. 3. PCR confirmation of the recombinant plasmids pZW, pZW1, pZW2 and pZW3. (A) 
PCR amplification of the inserted 0.26 kb flaA gene promoter from pZW. Lane M, 5 μl 1kb 
DNA ladder; Lane 0, 25 μl PCR negative control using pRY111 as the PCR template and 
sig28-F and sig28-R as primers; Lane 1, 25 μl PCR products amplified from pZW using 
primers sig28-F and sig28-R; (B) PCR amplification of inserted AR genes from pZW1, pZW2 
and pZW3. Lane M, 5 μl 1kb DNA ladder; Lane 1, 25 μl PCR products amplified from pZW1 
using primers of CAm-BamHIF and CAm-EcoRIR; Lane 2, 25 μl PCR products amplified 
from pZW2 using CSp-BamHIF and CSp-EcoRIR; Lane 3, 25 μl PCR products amplified from 
pZW3 using CKa-F and CKa-R. 
(A)                                (B) 
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